197 related articles for article (PubMed ID: 2580038)
1. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
Hess AD; Horwitz L; Beschorner WE; Santos GW
J Exp Med; 1985 Apr; 161(4):718-30. PubMed ID: 2580038
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Hess AD; Horwitz LR; Laulis MK; Fuchs E
Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
[TBL] [Abstract][Full Text] [Related]
3. Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.
Geller RB; Esa AH; Beschorner WE; Frondoza CG; Santos GW; Hess AD
Blood; 1989 Aug; 74(3):1165-71. PubMed ID: 2502208
[TBL] [Abstract][Full Text] [Related]
4. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Hess AD; Thoburn C; Horwitz L
Transplantation; 1998 Mar; 65(6):785-92. PubMed ID: 9539089
[TBL] [Abstract][Full Text] [Related]
5. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Hess AD; Thoburn CJ; Chen W; Horwitz LR
Biol Blood Marrow Transplant; 2000; 6(1):13-24. PubMed ID: 10707995
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Hess AD; Thoburn CJ
Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.
Glazier A; Tutschka PJ; Farmer ER; Santos GW
J Exp Med; 1983 Jul; 158(1):1-8. PubMed ID: 6345713
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
10. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
[TBL] [Abstract][Full Text] [Related]
11. Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Hess A; Thoburn C; Bright E; Horwitz L
Transplant Proc; 1997; 29(1-2):725-7. PubMed ID: 9123499
[No Abstract] [Full Text] [Related]
12. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Hess AD; Thoburn CJ; Chen W; Bright AE
Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
[TBL] [Abstract][Full Text] [Related]
13. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Fischer AC; Laulis MK; Horwitz L; Hess AD
Transplantation; 1991 Jan; 51(1):252-9. PubMed ID: 1898996
[TBL] [Abstract][Full Text] [Related]
15. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess AD; Horwitz LR; Laulis MK
Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
[No Abstract] [Full Text] [Related]
17. Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation.
Charak BS; Agah R; Mazumder A
Blood; 1992 Jul; 80(1):179-84. PubMed ID: 1611084
[TBL] [Abstract][Full Text] [Related]
18. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease.
Bryson JS; Caywood BE; Kaplan AM
J Immunol; 1991 Jul; 147(2):391-7. PubMed ID: 2071889
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in the rat. V. Lymphoid cell subclasses in the target organs during acute graft-versus-host disease.
Renkonen R
Transplantation; 1986 Jun; 41(6):704-8. PubMed ID: 2940737
[TBL] [Abstract][Full Text] [Related]
20. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
Hess AD; Bright EC; Thoburn C; Vogelsang GB; Jones RJ; Kennedy MJ
Blood; 1997 Mar; 89(6):2203-9. PubMed ID: 9058745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]